Total 169건 1 페이지
의료진 목록
번호 제목 글쓴이 조회 날짜
169
Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer.
NMSNUH 64 05-20
168
Generation of PET Attenuation Map for Whole-Body Time-of-Flight 18F-FDG PET/MRI Using a Deep Neural Network Trained with Simultaneously Reconstructed Activity and Attenuation Maps.
NMSNUH 72 05-20
167
Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.
NMSNUH 58 05-20
166
Identification of invasive and radionuclide imaging markers of coronary plaque vulnerability using radiomic analysis of coronary computed tomography angiography.
NMSNUH 68 05-19
165
Identification of invasive and radionuclide imaging markers of coronary plaque vulnerability using radiomic analysis of coronary computed tomography angiography.
NMSNUH 63 05-19
164
Identification of invasive and radionuclide imaging markers of coronary plaque vulnerability using radiomic analysis of coronary computed tomography angiography.
NMSNUH 208 05-19
163
Evaluation of maximum standardized uptake value at fluorine-18 fluorodeoxyglucose positron emission tomography as a complementary T factor in the eighth edition of lung cancer stage classification.
NMSNUH 57 05-19
162
Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer.
NMSNUH 64 05-19
161
Coronary computed tomography angiography vs. myocardial single photon emission computed tomography in patients with intermediate risk chest pain: a randomized clinical trial for cost-effectiveness comparison based on real-world cost.
NMSNUH 62 05-19
160
Prevalence of Positive 99 mTc-DPD Scintigraphy as an Indicator of the Prevalence of Wild-type Transthyretin Amyloidosis in the Elderly.
NMSNUH 77 05-19
159
Adenine Nucleotide Translocase 2 as an Enzyme Related to [18F] FDG Accumulation in Various Cancers.
NMSNUH 63 05-19
158
A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma.
NMSNUH 73 05-19
157
Significance of 18F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non-small-cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
NMSNUH 77 05-19
156
FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma.
NMSNUH 65 05-19
155
Yttrium-90 Radioembolization of the Right Inferior Phrenic Artery in 20 Patients with Hepatocellular Carcinoma.
NMSNUH 75 05-19
154
Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor.
NMSNUH 53 05-19
153
Monitoring tumor response to the vascular disrupting agent CKD-516 in a rabbit VX2 intramuscular tumor model using PET/MRI: Simultaneous evaluation of vascular and metabolic parameters.
NMSNUH 66 05-19
152
Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review.
NMSNUH 67 05-19
151
Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know.
NMSNUH 67 05-19
150
Prognostic Value of Baseline 18F-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study.
NMSNUH 59 05-19

검색